{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Hereditary haemorrhagic telangiectasia",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ibuprofen",
          "name": "Ibuprofen"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_warfarin",
          "name": "Warfarin"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_clopidogrel",
          "name": "Clopidogrel"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_rivaroxaban",
          "name": "Rivaroxaban"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_heparin",
          "name": "Heparin"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_dipyridamole",
          "name": "Dipyridamole"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_thrombin_inhibitors",
          "name": "Thrombin inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_nonsteroidal_anti_inflammatory_drugs",
          "name": "Nonsteroidal anti-inflammatory drugs"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_beta_blockers",
          "name": "Beta-blockers"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_anticoagulants",
          "name": "Anticoagulants"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_antithrombotic_agents",
          "name": "Antithrombotic agents"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.9,
        "components": {
          "mechanism_fit": 1.0,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.9,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Aspirin影响出血倾向，适合HHT患者"
          ],
          "indication_plausibility": [
            "已知Aspirin用于控制血小板聚集，适用于HHT"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.85,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Ibuprofen可能加重出血，需谨慎使用"
          ],
          "safety_risk": [
            "已知对出血风险的影响显著"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.95,
        "components": {
          "mechanism_fit": 1.0,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 1.0,
          "safety_risk": 0.0,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.95,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Warfarin严重影响凝血，绝对禁忌"
          ],
          "indication_plausibility": [
            "HHT患者需避免使用可影响出血的药物"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.85,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Clopidogrel增加出血风险，使用需谨慎"
          ],
          "safety_risk": [
            "应警惕对HHT患者的潜在影响"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.75,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Rivaroxaban影响血液凝固，使用需谨慎"
          ],
          "safety_risk": [
            "对HHT患者可能产生不良影响"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.7,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.7,
          "safety_risk": 0.25,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Heparin增加出血的可能性，使用需谨慎"
          ],
          "safety_risk": [
            "对HHT患者的潜在风险未明确"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.6,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.7,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Dipyridamole可能影响凝血，需强调使用的谨慎性"
          ],
          "safety_risk": [
            "影响HHT患者的潜在风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.65,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Thrombin inhibitors对出血有影响，须谨慎使用"
          ],
          "safety_risk": [
            "潜在影响需进一步探讨"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.6,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.4,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "NSAIDs已知影响出血风险，HHT患者需谨慎选择"
          ],
          "safety_risk": [
            "对出血倾向影响较高"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.55,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.5,
          "safety_risk": 0.4,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.55,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Beta-blockers对排除出血风险的影响不够明确"
          ],
          "safety_risk": [
            "临床证据不足以阐明对HHT患者的禁忌"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.9,
        "components": {
          "mechanism_fit": 1.0,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.9,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Anticoagulants对出血有直接影响，故对HHT患者构成禁忌"
          ],
          "safety_risk": [
            "对出血倾向的影响明确"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H12",
        "score": 0.8,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.0
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Antithrombotic agents增加出血风险，禁忌使用"
          ],
          "safety_risk": [
            "明确对出血的影响"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H3",
      "H1",
      "H11",
      "H2",
      "H4",
      "H12",
      "H5",
      "H6",
      "H8",
      "H7",
      "H9",
      "H10"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ibuprofen",
          "type": "Drug",
          "label": "Ibuprofen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_warfarin",
          "type": "Drug",
          "label": "Warfarin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_clopidogrel",
          "type": "Drug",
          "label": "Clopidogrel",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rivaroxaban",
          "type": "Drug",
          "label": "Rivaroxaban",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_heparin",
          "type": "Drug",
          "label": "Heparin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dipyridamole",
          "type": "Drug",
          "label": "Dipyridamole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thrombin_inhibitors",
          "type": "Drug",
          "label": "Thrombin inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nonsteroidal_anti_inflammatory_drugs",
          "type": "Drug",
          "label": "Nonsteroidal anti-inflammatory drugs",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anticoagulants",
          "type": "Drug",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_antithrombotic_agents",
          "type": "Drug",
          "label": "Antithrombotic agents",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_hereditary_haemorrhagic_telangiectasia",
          "type": "Disease",
          "label": "Hereditary haemorrhagic telangiectasia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Aspirin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ibuprofen",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Warfarin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Clopidogrel",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Rivaroxaban",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Heparin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Dipyridamole",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Thrombin inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Nonsteroidal anti-inflammatory drugs",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Antithrombotic agents",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_aspirin",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Aspirin已知影响出血倾向"
        },
        {
          "source": "drug_ibuprofen",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Ibuprofen可能加重出血"
        },
        {
          "source": "drug_warfarin",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.95,
          "agent": "Proponent",
          "rationale": "Warfarin严重影响凝血"
        },
        {
          "source": "drug_clopidogrel",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Clopidogrel增加出血风险"
        },
        {
          "source": "drug_rivaroxaban",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Rivaroxaban影响血液凝固"
        },
        {
          "source": "drug_heparin",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Heparin增加出血可能性"
        },
        {
          "source": "drug_dipyridamole",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Dipyridamole可能影响凝血"
        },
        {
          "source": "drug_thrombin_inhibitors",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Thrombin inhibitors对出血有影响"
        },
        {
          "source": "drug_nonsteroidal_anti_inflammatory_drugs",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "NSAIDs已知影响出血风险"
        },
        {
          "source": "drug_beta_blockers",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Beta-blockers在某些情况下可能影响出血"
        },
        {
          "source": "drug_anticoagulants",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Anticoagulants对出血有直接影响"
        },
        {
          "source": "drug_antithrombotic_agents",
          "target": "disease_hereditary_haemorrhagic_telangiectasia",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Antithrombotic agents增加出血风险"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_warfarin",
          "name": "Warfarin"
        },
        "score": 0.95,
        "graph_snapshot_ref": "GE_H3_round5",
        "key_assumptions": [
          "Warfarin对出血的影响明确且严重",
          "HHT患者应避免使用具有影响凝血的药物"
        ],
        "caveats": [
          "若有特殊患者背景需评估实际使用情况"
        ],
        "confidence": "high"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Warfarin对出血的影响",
          "reason": "Warfarin被证实对HHT患者构成绝对禁忌"
        }
      ],
      "remaining_gaps": [
        "其他抗凝药物的使用风险未充分评估"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [],
    "heuristics": []
  }
}